A better quality of maternal dietary fat reduces the chance of large-for-gestational-age infants: A prospective cohort study

Lima, Maria Carolina de; Santos, Izabela da Silva; Crivellenti, Lívia Castro; Sartorelli, Daniela Saes

doi:10.1016/j.nut.2021.111367

Cited by 4 publications

(4 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Those articles were read in full considering the inclusion and exclusion criteria were considered. Then, ten articles 10 11 12 13 14 15 16 17 18 19 were included in the present review. Figure 1 shows the inclusion flowchart.…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Prevalence of Preeclampsia in Brazil: An Integrative Review

Guida

Andrade

Pissinatti

et al. 2022

Rev Bras Ginecol Obstet

View full text Add to dashboard Cite

Objective To review literature and estimate the occurrence of preeclampsia and its complications in Brazil. Methods We performed an integrative review of the literature, and included observational studies published until August 2021 on the SciELO and PubMed databases that evaluated preeclampsia among pregnant women in Brazil. Other variables of interests were maternal death, neonatal death, hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome, and eclampsia. Three independent reviewers evaluated all retrieved studies and selected those that met inclusion criteria. A metanalysis of the prevalence of preeclampsia and eclampsia was also performed, to estimate a pooled frequency of those conditions among the studies included. Results We retrieved 304 studies after the initial search; of those, 10 were included in the final analysis, with a total of 52,986 women considered. The pooled prevalence of preeclampsia was of 6.7%, with a total of 2,988 cases reported. The frequency of eclampsia ranged from 1.7% to 6.2%, while the occurrence of HELLP syndrome was underreported. Prematurity associated to hypertensive disorders ranged from 0.5% to 1.72%. Conclusion The frequency of preeclampsia was similar to that reported in other international studies, and it is increasing in Brazil, probably due to the adoption of new diagnostic criteria. The development of a national surveillance network would be essential to understand the problem of hypertensive disorders of pregnancy in Brazil.

show abstract

Section: Resultsmentioning

confidence: 99%

“…Overall, 2,988 cases of preeclampsia were reported; the prevalence ranged from 2.31% 11 to 14.15%. 13 Seven studies 10 13 14 15 16 17 18 did not report the occurrence of eclampsia. In the other 3 studies that reported eclampsia, it ranged from 1.66% 19 to 6.19%.…”

Section: Resultsmentioning

confidence: 99%

Prevalence of Preeclampsia in Brazil: An Integrative Review

Guida

Andrade

Pissinatti

et al. 2022

Rev Bras Ginecol Obstet

View full text Add to dashboard Cite

show abstract

“…Although the primary focus of medical nutritional therapy (MNT) in GDM is to ensure adequate caloric intake for fetal development and maintain euglycemia in the mother, research from randomized controlled trials indicates that fetal growth is primarily influenced by fatty acids rather than glucose as an independent variable[ 87 ]. According to a prospective cohort study conducted by de Lima et al [ 88 ], a higher consumption of n -3 fatty acids was associated with a decreased likelihood of having a neonate with a large gestational age (LGA). Additionally, women with a higher intake of polyunsaturated fatty acids, including both n -3 and n -6, and a higher ratio of polyunsaturated fats to saturated fats (P/S), as well as a higher ratio of hypocholesterolemic to hypercholesterolemic fatty acids (h/H), had a significantly lower probability of giving birth to a neonate with macrosomia, with a potential reduction of up to 49%.…”

Section: Non-pharmacological Approach For Gestational Diabetesmentioning

confidence: 99%

Gestational diabetes mellitus and COVID-19: The epidemic during the pandemic

Mendez,

Alpuing Radilla,

Delgadillo Chabolla

et al. 2023

World J Diabetes

View full text Add to dashboard Cite

The incidence of type 2 diabetes mellitus is growing in epidemic proportions and has become one of the most critical public health concerns. Cardiovascular complications associated with diabetes are the leading cause of morbidity and mortality. The cardiovascular diseases that accompany diabetes include angina, myocardial infarction, stroke, peripheral artery disease, and congestive heart failure. Among the various risk factors generated secondary to hyperglycemic situations, advanced glycation end products (AGEs) are one of the important targets for future diagnosis and prevention of diabetes. In the last decade, AGEs have drawn a lot of attention due to their involvement in diabetic patho-physiology. AGEs can be derived exogenously and endogenously through various pathways. These are a nonhomogeneous, chemically diverse group of compounds formed nonenzymatically by condensation between carbonyl groups of reducing sugars and free amino groups of protein, lipids, and nucleic acid. AGEs mediate their pathological effects at the cellular and extracellular levels by multiple pathways. At the cellular level, they activate signaling cascades via the receptor for AGEs and initiate a complex series of intracellular signaling resulting in reactive oxygen species generation, inflammation, cellular proliferation, and fibrosis that may possibly exacerbate the damaging effects on cardiac functions in diabetics. AGEs also cause covalent modifications and cross-linking of serum and extracellular matrix proteins; altering their structure, stability, and functions. Early diagnosis of diabetes may prevent its progression to complications and decrease its associated comorbidities. In the present review, we recapitulate the role of AGEs as a crucial mediator of hyperglycemia-mediated detrimental effects in diabetes-associated complications. Furthermore, this review presents an overview of future perspectives for new therapeutic interventions to ameliorate cardiovascular complications in diabetes.

show abstract

“…A prospective cohort study showed that pregnant women with better dietary fat quality (low saturated fatty acids, high polyunsaturated fatty acids) had a lower incidence of LGA. 20 An intervention aimed at preventing LGA and controlling birth weight provided guidance on a low-glycaemic, low-saturated fat diet and physical activity for pregnant women who were overweight or obese. The intervention reduced the incidence of GDM and LGA significantly.…”

Section: Introductionmentioning

confidence: 99%

Lipid-focused dietary education intervention in pregnant women: study protocol for an open-label, parallel, randomised, intervention study addressing adverse pregnancy outcomes in China

Zhang,

Gao,

Zhu

et al. 2024

BMJ Open

View full text Add to dashboard Cite

IntroductionThe incidence of infants who are large-for-gestational-age (LGA) is on the rise in China, and its detrimental effects on health have received increasing attention. Diet-based interventions have the potential to reduce adverse birth outcomes, particularly in decreasing the occurrence of LGA infants. We aim to evaluate the effect of lipid-focused diet education based on the theories of behaviour change in pregnant women on maternal and offspring outcomes through a randomised controlled trial.Methods and analysisWe have designed an open-label, parallel, multicentre randomised controlled trial in collaboration with three hospitals in Beijing, China.Pregnant women will be recruited before reaching 12 weeks of gestation and will be randomised in a 1:1:1 ratio into three arms: (1) online education arm, (2) pregnancy nutrition checklist and ‘one-page flyer’ arm and (3) routine antenatal education. The primary outcome LGA will be recorded at birth. Demographic information, physical activity, sleep and medical history will be collected through questionnaires and case cards prior to enrolment. Questionnaires will also be used to collect dietary behaviours and psychosocial factors of pregnant women at enrolment, at 24–28 weeks and 34–36 weeks of gestation. Additionally, information on breastfeeding and complementary food supplementation for infants and young children will be obtained through questionnaires. Physical development indicators of children and taste tests will be assessed 3 years after delivery.Ethics and disseminationThe study has received ethical approval from the Capital Medical University Ethics Committee and other collaborating study centres. Informed consent will be introduced to pregnant women, and their consent will be obtained. The findings will be reported in relevant national and international academic conferences and peer-reviewed publications.Trial registration numberChiCTR2300071126.

show abstract

A better quality of maternal dietary fat reduces the chance of large-for-gestational-age infants: A prospective cohort study

Cited by 4 publications

References 21 publications

Prevalence of Preeclampsia in Brazil: An Integrative Review

Prevalence of Preeclampsia in Brazil: An Integrative Review

Gestational diabetes mellitus and COVID-19: The epidemic during the pandemic

Lipid-focused dietary education intervention in pregnant women: study protocol for an open-label, parallel, randomised, intervention study addressing adverse pregnancy outcomes in China

Contact Info

Product

Resources

About